The Protective Effects of Compound 21 and Valsartan in Isoproterenol-Induced Myocardial Injury in Rats
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Protective Effects of Compound 21 and Valsartan in Isoproterenol-Induced Myocardial Injury in Rats
Authors
Keywords
-
Journal
Cardiovascular Toxicology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-09
DOI
10.1007/s12012-020-09590-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The protective effect of kaempferol on heart via the regulation of Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart failure in diabetic rats
- (2019) Long Zhang et al. DRUG DEVELOPMENT RESEARCH
- Effect of Kaempferol Pretreatment on Myocardial Injury in Rats
- (2018) Anamika Vishwakarma et al. Cardiovascular Toxicology
- Nicorandil enhances the efficacy of mesenchymal stem cell therapy in isoproterenol-induced heart failure in rats
- (2015) Sarah S. Mohamed et al. BIOCHEMICAL PHARMACOLOGY
- Selective activation of angiotensin AT2receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
- (2015) E Bruce et al. BRITISH JOURNAL OF PHARMACOLOGY
- Practical approaches for the treatment of chronic heart failure: Frequently asked questions, overlooked points and controversial issues in current clinical practice
- (2015) Yuksel Cavusoglu et al. Anatolian Journal of Cardiology
- Angiotensin Type 2 Receptor Stimulation Ameliorates Left Ventricular Fibrosis and Dysfunction via Regulation of Tissue Inhibitor of Matrix Metalloproteinase 1/Matrix Metalloproteinase 9 Axis and Transforming Growth Factor β1 in the Rat Heart
- (2013) Dilyara Lauer et al. HYPERTENSION
- Comparing Effects of Lacidipine, Ramipril, and Valsartan Against Experimentally Induced Myocardial Infarcted Rats
- (2012) Yasin Bayir et al. Cardiovascular Toxicology
- Heart Failure in Hypertension
- (2012) Vasiliki V. Georgiopoulou et al. DRUGS
- Compound 21 Induces Vasorelaxation via an Endothelium- and Angiotensin II Type 2 Receptor-Independent Mechanism
- (2012) Koen Verdonk et al. HYPERTENSION
- Valsartan, an Angiotensin II Receptor Blocker, Attenuates Cardiac Dysfunction and Oxidative Stress in Isoproterenol-Induced Cardiotoxicity
- (2011) Sameer Goyal et al. Cardiovascular Toxicology
- Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury
- (2011) Yanfei Qi et al. EXPERIMENTAL PHYSIOLOGY
- Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats
- (2011) Asia Rehman et al. HYPERTENSION
- Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats
- (2010) S Bosnyak et al. BRITISH JOURNAL OF PHARMACOLOGY
- Differential Regulation of Proteasome Function in Isoproterenol-Induced Cardiac Hypertrophy
- (2010) Oliver Drews et al. CIRCULATION RESEARCH
- Non-peptide AT2-receptor agonists
- (2010) U Muscha Steckelings et al. CURRENT OPINION IN PHARMACOLOGY
- Valsartan
- (2010) Henry R. Black et al. DRUGS
- Angiotensin II Type 2 Receptor Stimulation
- (2008) Elena Kaschina et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More